Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 25
1977 5
1978 5
1979 1
1980 1
1981 2
1983 4
1984 1
1985 2
1986 2
1987 1
1988 3
1989 2
1991 1
1993 1
1994 1
1997 1
1998 3
1999 1
2000 1
2001 1
2004 2
2006 2
2007 3
2008 13
2009 4
2010 1
2011 1
2012 2
2013 8
2014 3
2015 1
2016 4
2017 2
2018 1
2019 1
2020 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Diflucortolone valerate. Asian experience.
Hoppe G. Hoppe G. Drugs. 1988;36 Suppl 5:24-33. doi: 10.2165/00003495-198800365-00006. Drugs. 1988. PMID: 3254827
More than 10 years ago, diflucortolone valerate (Nerisone, Nerisona) was introduced in Germany and soon after in Asian countries in a concentration of 0.1% in cream, ointment and fatty ointment bases. 897 patients were included in the first Southeast Asian multicent …
More than 10 years ago, diflucortolone valerate (Nerisone, Nerisona) was introduced in Germany and soon after in Asian countri …
Treatment of angular cheilitis: A narrative review and authors' clinical experience.
Cabras M, Gambino A, Broccoletti R, Lodi G, Arduino PG. Cabras M, et al. Oral Dis. 2020 Sep;26(6):1107-1115. doi: 10.1111/odi.13183. Epub 2019 Sep 11. Oral Dis. 2020. PMID: 31464357 Free article. Review.
Our group found in 1% isoconazole nitrate (ISN) and 0.1% diflucortolone valerate (DFV) ointment the most consistent AC treatment, due to the broad spectrum of ISN against many species of dermatohpytes and bacteria, and the anti-inflammatory properties displayed by D …
Our group found in 1% isoconazole nitrate (ISN) and 0.1% diflucortolone valerate (DFV) ointment the most consistent AC treatme …
The association of isoconazole-diflucortolone in the treatment of pediatric tinea corporis.
Veraldi S, Schianchi R, Pontini P, Gorani A. Veraldi S, et al. J Dermatolog Treat. 2018 Mar;29(2):200-201. doi: 10.1080/09546634.2017.1360988. Epub 2017 Sep 19. J Dermatolog Treat. 2018. PMID: 28753055
METHODS: In 2012, we decided to treat all children with a single lesion of tinea corporis with a combination of 1% isoconazole nitrate and 0.1% diflucortolone valerate cream (one application/day for 5-7 days), followed by a treatment with isoconazole or clotrimazole …
METHODS: In 2012, we decided to treat all children with a single lesion of tinea corporis with a combination of 1% isoconazole nitrate and 0 …
Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
Reckers R, Wendt H. Reckers R, et al. Clin Ther. 1980;3(3):190-3. Clin Ther. 1980. PMID: 7459929
The visual assessment of vasoconstrictive activity after 10 hours revealed a statistically significant superiority of diflucortolone valerate in its fat base over the corresponding galenical formulations of fluocinonide, clobetasol-17-propionate, and hydrocortisone- …
The visual assessment of vasoconstrictive activity after 10 hours revealed a statistically significant superiority of diflucortolone …
Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
Coleman GL, Kanfer I, Haigh JM. Coleman GL, et al. Dermatologica. 1978;156(4):224-30. doi: 10.1159/000250920. Dermatologica. 1978. PMID: 342295 Clinical Trial.
The blanching activities and hence bioavailabilities of the cream, ointment and fatty ointment preparations of Nerisone and Temetex (diflucortolone valerate 0.1%) were evaluated using an occluded and unoccluded blanching assay. ...Statistical analysis showed no sign …
The blanching activities and hence bioavailabilities of the cream, ointment and fatty ointment preparations of Nerisone and Temetex (difl …
Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS, Mahmoud AA, Ammar HO, Elkheshen SA. Abdel-Salam FS, et al. J Liposome Res. 2017 Mar;27(1):41-55. doi: 10.3109/08982104.2016.1149866. Epub 2016 Mar 9. J Liposome Res. 2017. PMID: 26956098
OBJECTIVE: The aim of this study was to produce semisolid nanostructured lipid carrier (NLC) formulations, for topical delivery of the corticosteroid drug, diflucortolone valerate (DFV), with minimum systemic absorption. METHOD: NLC formulations were developed using …
OBJECTIVE: The aim of this study was to produce semisolid nanostructured lipid carrier (NLC) formulations, for topical delivery of the corti …
Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations.
Özcan I, Azizoğlu E, Senyiğit T, Özyazıcı M, Özer Ö. Özcan I, et al. Int J Nanomedicine. 2013;8:461-75. doi: 10.2147/IJN.S40519. Epub 2013 Jan 30. Int J Nanomedicine. 2013. PMID: 23390364 Free PMC article.
The objective of this study was to prepare a suitable formulation for dermal delivery of diflucortolone valerate (DFV) that would maintain the localization in skin layers without any penetration and to optimize efficiency of DFV. ...
The objective of this study was to prepare a suitable formulation for dermal delivery of diflucortolone valerate (DFV) that wo …
111 results